The Effect of Birth Plans on Obstetrical Outcomes
1 other identifier
interventional
80
1 country
1
Brief Summary
The study design is a prospective, single institution, randomized control trial in which the introduction of a birth plan is the intervention and a comparison of the rate of Caesarean sections between participants in the control group (no birth plan) and the experimental group (birth plan) is the primary outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pregnancy
Started Oct 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2015
CompletedFirst Posted
Study publicly available on registry
August 18, 2015
CompletedStudy Start
First participant enrolled
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedSeptember 30, 2019
September 1, 2019
1.8 years
July 31, 2015
September 26, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Caesarean sections (yes/no variable)
Was a Caesarean section used to deliver the baby? (yes/no variable abstracted from medical chart)
4 weeks
Secondary Outcomes (3)
neonatal outcome: APGAR<7
4 weeks
neonatal outcome: low birth weight
4 weeks
Childbirth Satisfaction (questionnaire)
4 weeks
Study Arms (2)
birth plan
EXPERIMENTALUse of birth plan
no birth plan
NO INTERVENTIONNo use of birth plan
Interventions
Eligibility Criteria
You may qualify if:
- Patient has singleton pregnancy
- Patient has baby with cephalic presentation
- Patient is at less than 34 weeks gestation
You may not qualify if:
- Patient has planned Caesarean section
- Patient has planned pre-existing birth plan
- Patient has intrauterine fetal demise
- Patient having a fetus with congenital anomalies
- Existence of intrauterine growth restriction
- Existence of oligohydramnios
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr Rashmi Bhargava
Regina, Saskatchewan, S4P 0L9, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Rashmi Bhargava, MD
RQHR
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
July 31, 2015
First Posted
August 18, 2015
Study Start
October 1, 2015
Primary Completion
August 1, 2017
Study Completion
August 1, 2017
Last Updated
September 30, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share